Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondria-dependent apoptosis pathway (also called the mitochondrial or intrinsic apoptosis pathway) is a programmed cell death pathway controlled by mitochondrial signals. It is triggered by internal stressors such as DNA damage, oxidative stress, or lack of survival factors. Central to this pathway are Bcl-2 family proteins, which regulate mitochondrial outer membrane permeabilization (MOMP). Upon activation by pro-apoptotic factors (like Bax, Bak, Bad, Bid, Puma, Bim, and Noxa), mitochondria release cytochrome c and other proteins into the cytosol. Cytochrome c interacts with Apaf-1 to form the apoptosome, which activates initiator caspase-9, leading to a cascade that activates executioner caspases (mainly caspase-3, -6, and -7) and results in controlled cell dismantling. This pathway is frequently dysregulated in cancer and plays a critical role in tissue homeostasis and disease.
Induction of mitochondrial outer membrane permeabilization (MOMP); Activation/inhibition of Bcl-2 family members (pro-apoptotic and anti-apoptotic); Promotion/release of cytochrome c to activate apoptosome and caspases
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondria-dependent apoptosis pathway.